May 2025

71 Articles

No Section

Chronicity of disease mandates quality-of-life prioritization – a role for digital health and patient-reported outcome measures

10 March 2025
Author(s): Maximilian Boesch, Florent Baty, Sanjay Kalra, Martin H. Brutsche, Frank Rassouli

The field of internal medicine is evolving at unprecedented speed and humankind is steadily growing older. Progress in diagnostics and treatment have improved the prognosis of many diseases and led... more

Clinical Insights

Undiagnosed celiac disease. The conundrum of unveiling the dark side of the moon

1 April 2025
Author(s): Gino Roberto Corazza, Marco Vincenzo Lenti

Celiac disease (CD) is a gluten-induced, inflammatory disease of the small intestine, characterized by high and rising prevalence, huge clinical variability, and increased co-morbidity and mortality... more

The emperor's new clothes and the case of vitamin D and cardiovascular risk. A few thoughts after the guidelines of the American Society of Endocrinology

14 February 2025
Author(s): Claudio Cimminiello

As in the famous Christian Andersen fairy tale, the recent guidelines of the American Society of Endocrinology [1] have confirmed that the king is naked, significantly diminishing the role of... more

Commentary

Lymphangioplasty 4.0 as a therapeutic and educational opportunity for (Lymph)edema

28 March 2025
Author(s): Anna Poretto, Jean Paul Belgrado, Giacomo Rossitto

In this issue of the European Journal of Internal Medicine (EJIM), Mazzolai et al. report on safety and preliminary efficacy of a novel device, that uses subcutaneously implanted catheters to provide... more

Acute exacerbation of chronic obstructive pulmonary disease: An underestimated cardiovascular risk factor

11 March 2025
Author(s): Valentine Mismetti, Laurent Bertoletti

Chronic obstructive pulmonary disease (COPD) is a widespread respiratory disease associated with significant morbidity and mortality [1,2]. It ranks among the leading causes of death and is expected... more

Sodium-glucose co-transporter 2 inhibitors in acute heart failure: What are you waiting for?

6 March 2025
Author(s): Herminio Morillas, Josep Comin-Colet

Sodium-glucose co-transporter 2 inhibitors (SGLT2i) were initially discovered as a compound present in roots, leaves and fruits of the apple tree in 1835. However, it was not until the beginning of... more

The prothrombotic effects of Lipoprotein (a) and atherosclerosis

3 March 2025
Author(s): Avishay Elis

Lipoprotein (a) [Lp(a)] is a plasma lipoprotein consisting of a cholesterol-rich LDL particle with one molecule of apolipoprotein B100 and an additional protein which has sequence homology with... more

The misalignment between chronotype and sleep time: Friend or foe?

3 March 2025
Author(s): Eleonora Tobaldini, Angelica Carandina, Nicola Montano

We spend approximately one third of our lifetime in sleep, a complex physiological process which is an established health determinant. In the last decades, it has been demonstrated that reduction of... more

Catheter ablation of atrial fibrillation in older patients: The need for a comprehensive evaluation and management

1 March 2025
Author(s): Mario Bo, Marco Proietti, Roberto Presta

Atrial fibrillation (AF) affects approximately one-third of individuals aged 80 years and over and is associated with a wide range of adverse clinical outcomes, including heart failure (HF), ischemic... more

Redefining thiamine requirements in alcohol use disorder: Aligning treatment with neurocognitive needs

28 February 2025
Author(s): Giovanna Di Sario, Tommaso Dionisi, Giovanni Addolorato

Alcohol Use Disorder (AUD) is a pervasive condition that often presents with marked neurocognitive consequences. From mild executive and memory deficits to severe conditions such as Wernicke–... more

Ischemic heart failure etiology: A misleading definition?

28 February 2025
Author(s): Alexander Schmitt, Michael Behnes, Ibrahim Akin, Tobias Schupp

Heart failure (HF) remains a leading cause of morbidity and mortality despite advances in interventional and pharmacological therapies [1,2]. Beyond the classification based on left ventricular... more

Atrial fibrillation screening: The importance of the patient perspective

24 February 2025
Author(s): Jacopo Francesco Imberti, Davide Antonio Mei, Giuseppe Boriani

Atrial fibrillation (AF) is the most common cardiac arrhythmia, with its prevalence increasing significantly in older adults and individuals with comorbidities [1]. Beyond being a major contributor... more

Internal Medicine Flashcard

Chest pain, inflammatory syndrome and headache

9 March 2025
Author(s): Romain Batton, Ludivine Lebourg, Gaëtan Sauvêtre

A 51-year-old white man presented to the internal medicine department with altered general condition and significant weight loss of 14 kg in 3 months. The main symptom was cervical pain and headache... more

Linear lesions on the chest

3 February 2025
Author(s): Pei-Chun Weng, Pei-Rong Gao

A 70-year-old man with a history of lung adenocarcinoma was admitted to our hospital for chemotherapy. During his hospitalization, eruptive papules with a dermatomal distribution developed on his... more

When skin and lung meet

30 January 2025
Author(s): Sara Piciucchi, Stefano Oldani, Venerino Poletti

A 50-year-old male, heavy smoker (>30 p/Y), presented to E.R. because of chest pain. In his recent clinical history, he had relapsing papular-purpuric small lesions in the limbs, trunk and arms... more

A man with trismus and decubitus ulcers

21 January 2025
Author(s): Rika Okamoto, Masaki Itagane, Mitsuyo Kinjo

A 65-year-old man with a history of binge drinking who had engaged in gardening was brought to our hospital for lethargy. On physical examination, temperature was 35.0 °C, blood pressure was 70/50... more

A 73-year-old man with purpura and fever

15 January 2025
Author(s): Ivânia Soares, Inês Pereira Amaral, Paulo Filipe

A 73-year-old man presented to our dermatology department with a four-week history of palpable purpura on the lower limbs. His medical history included a suspicion of polymyalgia rheumatica based on... more

Invited Review Article

What is new in the management of coeliac disease?

1 February 2025
Author(s): Mohamed G Shiha, David S Sanders

Coeliac disease is a chronic immune-mediated disorder triggered by gluten ingestion in genetically predisposed individuals [1]. It is characterised by immune-mediated inflammation and damage to the... more

Letter to the Editor

Apixaban and the improved psychologic profile in frailty and disability. Myth or reality?

18 March 2025
Author(s): Stefano Fumagalli, Giuseppe Di Pasquale, Giulio Molon, Giancarlo Agnelli, Niccolò Marchionni, APULEIO Study Investigators

We thank Hung and Chao for their interest in our work [1]. Their letter [2] allowed us to specify some relevant aspects about APULEIO (Treatment satisfaction of Italian patients undergoing Apixaban... more

Building on the UTILY Study: Exploring uncharted aspects of multidrug-resistant pathogens in urinary tract infections. Author's reply

8 March 2025
Author(s): Lorenzo Onorato, Margherita Macera, Caterina Monari, Nicola Coppola

Dear Editor,

More on peripheral artery disease and air pollution. Author's reply

7 March 2025
Author(s): Chiara Di Blasi, Alberto Maria Settembrini, Massimo Stafoggia, Matteo Renzi, Pier Mannuccio Mannucci

Dear Editor,

Critical considerations for sodium bicarbonate therapy in metabolic acidosis: Addressing confounding factors and methodological limitations

5 March 2025
Author(s): Danyang Liu

I recently read the paper by Tong et al., which explores the clinical effects of sodium bicarbonate (SOB) therapy in metabolic acidosis, focusing on the interaction between baseline chloride levels... more

Non-statistical significance and clinical relevance: Are we chasing shadows in the air pollution-peripheral artery disease debate?

21 February 2025
Author(s): Stephan Peronard Mayntz, Kasper Emil Rosenbech

The impact of air pollution on cardiovascular diseases has been a subject of extensive research, with compelling evidence linking long-term exposure to pollutants such as particulate matter (PM2.5),... more

Reevaluating hypoxia and cancer as determinants of prognosis in COPD and Takotsubo syndrome. Author's reply

8 February 2025
Author(s): Luca Arcari, Giacomo Tini, Beatrice Musumeci, Emanuele Barbato, Luca Cacciotti

We thank García-Martí et al. for the interest in our study recently published in the European Journal of Internal Medicine [1], and here we provide further analysis following their stimulating... more

Building on the UTILY Study: Exploring uncharted aspects of multidrug-resistant pathogens in urinary tract infections

1 February 2025
Author(s): Heng Xiao, Wen Xiao, Xinmin Deng

We have carefully reviewed the article by Onorato et al., published in the European Journal of Internal Medicine [1]. The study provides important insights into the prevalence of multidrug-resistant... more

Frailty, disability and patient-reported outcomes in apixaban users

30 January 2025
Author(s): Stefano Fumagalli, Giuseppe Di Pasquale, Giulio Molon, Giancarlo Agnelli, Niccolò Marchionni, APULEIO Study Investigators

atrial fibrillation (AF) is the arrhythmia most frequently diagnosed in older patients with a prevalence higher than 10 % in subjects ≥70 years [1]. The incidence of venous thromboembolism (VTE),... more

Vaginal self-sampling for human papillomavirus to improve cervical cancer screening in patients with immune-mediated inflammatory diseases

12 January 2025
Author(s): Tiphaine Goulenok, Chrystelle François, Valentine Marie Ferré, Arthur Mageau, Karim Sacré, APOSY Study Group

Dear Editor,

Reevaluating hypoxia and cancer as determinants of prognosis in COPD and Takotsubo syndrome

12 January 2025
Author(s): Gonzalo García-Martí, Ravi Vazirani, Hernán Mejía-Rentería, Iván J. Núñez-Gil

Dear Editor,

Rituximab in Immune-mediated thrombotic thrombocytopenic purpura

2 January 2025
Author(s): Jie Li, Jiashuo Guo, Ruirui Yuan, Liying Xue

Thrombotic thrombocytopenic purpura (TTP) is a rare and potentially fatal thrombotic microangiopathy, defined by a mechanical hemolytic anemia, severe thrombocytopenia, and visceral ischemia due to... more

Refining the understanding of cardiovascular risk following COPD exacerbations: Opportunities for stratified and multidisciplinary approaches

24 December 2024
Author(s): Rujian Yu, Lamei Zou

We have carefully reviewed the article by Calabria et al., published in the European Journal of Internal Medicine [1]. This study, based on a comprehensive database analysis, highlights the... more

Refining risk assessment for intra-abdominal infections in immunocompromised intensive care unit patients

24 December 2024
Author(s): Yinfang Wu, Qi Zhao

The study by Paiva and colleagues [1] provides valuable insights into intra-abdominal infections (IAI) in immunocompromised intensive care unit (ICU) patients, highlighting similarities and... more

Analysis of “characteristics of familial mediterranean fever disease after 65 years of age”

18 December 2024
Author(s): Kazim Besirli

I have read the article “Characteristics of Familial Mediterranean fever (FMF) after 65 years of age” with great interest. The study provides valuable insights into the clinical features and... more

Hypertension – a global problem requiring a comprehensive approach

12 December 2024
Author(s): Agnieszka Zalewska, Anna Litwińska-Kmiecik, Alicja Wiśniewska

We read with great interest a recently published study by Rikuta Hamaya, Molin Wang, Ellen Hertzmark, et al. regarding modifiable lifestyle factors in the primordial prevention of hypertension [1].... more

Risk for hospital-treated infections in dermatitis herpetiformis and coeliac disease

12 December 2024
Author(s): Camilla Pasternack, Matti Karppelin, Kaisa Hervonen, Katri Kaukinen, Teea Salmi, Celiac Disease Study Group

Dear Editor,

Risk of injurious falls in older people with atrial fibrillation

10 December 2024
Author(s): Anna Litwińska-Kmiecik, Agnieszka Zalewska

Dear editor,

Use of betablockers in post-myocardial infarction patients in a real-world setting

9 December 2024
Author(s): Marta Baviera, Anna Zanovello, Luisa Ojeda-Fernández, Mauro Molteni, Claudio Cimminiello

For many years, the main guidelines have been recommending the use of betablocker therapy in patients after myocardial infarction (MI) [1,2]. This recommendation entails a high class and grade for... more

High-risk allogeneic stem cells transplantation in advanced age patients with uncontrolled sickle cell disease

8 December 2024
Author(s): Frederic Garban, Caroline Makowski, Claude Eric Bulabois, Laurence Bouillet, Mathieu Meunier

Sickle cell disease (SCD) is a recessive monogenic disease where a single nucleotide mutation of the HBB gene, encoding the β-globin chain of hemoglobin (Hb), leads to the synthesis of HbS.... more

Seasonality of diabetic ketoacidosis in hot climate

28 November 2024
Author(s): Fahmi Abu Ghalion, Mai Ofri, Victor Novack, Lena Novack

Diabetic ketoacidosis (DKA) is a life-threatening condition arising from an absolute or relative insulin deficiency, leading to hyperglycemia and ketone body accumulation in the blood with metabolic... more

Validating ChatGPT's role in systematic reviews and meta-analyses: A case study on GLP-1 receptor agonists and all-cause mortality

28 November 2024
Author(s): Lefteris Teperikidis, Paschalis Karakasis, Dimitrios Patoulias, Aristi Boulmpou, Dimitrios Kouzoukas, AIMES – AI for Meta-Analysis and Evidence Synthesis

Dear Editor,

Refining metabolic health assessment in inflammatory bowel disease risk prediction

29 October 2024
Author(s): Yinfang Wu, Weixing Xu

Mi et al.'s investigation [1], drawing upon the United Kingdom (UK) Biobank resource, delves into the interplay between metabolic health and genetic predisposition to inflammatory bowel disease (IBD... more

Original Article

Differential modulations of miRNAs in patients with systemic sclerosis-associated skeletal muscle loss

1 April 2025
Author(s): Federica Tambaro, Antonietta Gigante, Carmen Gallicchio, Chiara Pellicano, Cesarina Ramaccini, Roberta Belli, Maria Ludovica Gasperini-Zacco, Edoardo Rosato, Maurizio Muscaritoli

Systemic sclerosis (SSc) is a rare, complex autoimmune disease characterized by vasculopathy and fibrosis of the skin and internal organs. Clinical manifestations of SSc are the result of the... more

Association of miR-126-3p, miR-1260b and miR-374a-5p with the incidence of heart failure in a population-based cohort: the Hortega Follow-Up Study

27 March 2025
Author(s): Maria Grau-Perez, Olga Martinez-Arroyo, Marta Rubia-Martinez, Ana Flores-Chova, Zulema Rodriguez-Hernandez, Pablo Fernández-Navarro, Anna Gonzalez-Neira, Maria Rosario Alonso, Guillermo Pita, Silvia Pineda, Juan Carlos Martin-Escudero, Ana Ortega, Josep Redon, Maria Tellez-Plaza, Raquel Cortes

The potential use of microRNAs (miRNAs), endogenous RNAs of approximately 22 nucleotides that play a regulatory role by targeting mRNAs for translational excision or repression [1,2], has gained... more

Doppler ultrasound unveils splanchnic arteries ischemia allowing early successful revascularization in symptomatic systemic sclerosis patients

25 March 2025
Author(s): Giulia Bandini, Corrado Campochiaro, Gabriele Ciuti, Domenico Baccellieri, Vincenzo Ardita, Silvia Bellando Randone, Khadija El Aoufy, Dilia Giuggioli, Martina Orlandi, Lorenzo Dagna, Roberto Chiesa, Marco Matucci Cerinic, Alberto Moggi Pignone

Systemic sclerosis (SSc) is an autoimmune rheumatic disease where vasculopathy is one of the main hallmarks, and the gastrointestinal (GI) tract is one of the most affected systems [1,2]. In fact,... more

Recurrent pericarditis with normal C-reactive protein: Clinical and laboratory features, biomarkers and outcome in a non-inflammatory phenotype

19 March 2025
Author(s): Ruggiero Mascolo, Maddalena Alessandra Wu, Silvia Berra, Matteo Vidali, Massimo Pancrazi, Lucia Trotta, Elisa Ceriani, Enrica Negro, Lisa Serati, Luisa Carrozzo, Elisa Calabrò, Ferruccio Ceriotti, Alessandro Andreis, Valentino Collini, Massimo Imazio, Antonio Brucato

Idiopathic recurrent acute pericarditis (IRAP) significantly affects patients’ quality of life, imposing a psychosocial burden, alongside risks of complications, treatment-related adverse effects,... more

Gendered social determinants of health and risk of major adverse outcomes in atrial fibrillation

9 March 2025
Author(s): Jonathan Houle, Marco Proietti, Valeria Raparelli, Clare L Atzema, Colleen M Norris, Michal Abrahamowicz, Gregory YH Lip, Giuseppe Boriani, Louise Pilote

The global population is aging and the burden of atrial fibrillation (AF) is expected to rise sharply over the next decades [1,2]. Beyond a fivefold increase in stroke risk, individuals with AF... more

Assessment of nasal pressure swing predicts respiratory support dependency in patients with hypoxic respiratory failure

7 March 2025
Author(s): Roberto Tonelli, Giulia Bruzzi, Riccardo Fantini, Luca Tabbì, Antonio Moretti, Francesco Livrieri, Ivana Castaniere, Stefania Cerri, Daniele Puggioni, Federico Guidotti, Gianluca Bellesia, Alessandro Marchioni, Enrico Clini

In recent years, particularly following the COVID-19 pandemic, there has been increasing interest in non-invasive respiratory support (RS) to manage the acute hypoxemic respiratory failure (AHRF) [1–... more

Assessment of cardiovascular, thromboembolic and cancer risk in patients eligible for treatment with Janus Kinase inhibitors: The JAK-ERA multidisciplinary consensus

20 February 2025
Author(s): Lorenzo Dagna, Alessia Alunno, Nicola Farina, Giancarlo Agnelli, Claudio Borghi, Roberto Caporali, Antonio Costanzo, Silvio Danese, Filippo De Braud, Gian Domenico Sebastiani, Carlo Maurizio Montecucco

Janus kinase inhibitors (JAKi), a class of targeted synthetic disease-modifying antirheumatic drugs, have significantly impacted clinical practice in the treatment of various autoimmune and... more

Promoting women's careers in life science and medicine: A position paper from the “International Women in Intensive Medicine” network

15 February 2025
Author(s): Olfa Hamzaoui, Florence Boissier, Carla Teixera, Luciana Mascia, Irene Aragao, Sahar Bahrami, Maria Cruz Martin Delgado, Jannicke Mellin-Oslen, Jordi Rello, Francesca Rubulotta, iWIN network members in annex 1

It is well-established that women are underrepresented in leadership positions [1], undervalued in their academic careers, and experience gender discrimination in scientific and healthcare... more

Hypertensive heart disease in older patients: considerations for clinical practice

15 February 2025
Author(s): Miguel Camafort, Alexandros Kasiakogias, Enrico Agabiti-Rosei, Stefano Masi, Panagiotis Iliakis, Athanase Benetos, Jin-Ok Jeong, Hae-Young Lee, Maria Lorenza Muiesan, Isabella Sudano, Costas Tsioufis, European Society of Hypertension Working Group on Hypertension and the Heart

Appropriate blood pressure (BP) control remains the main therapeutic strategy to address the adverse sequelae of hypertension irrespective of a patient's age [1]. A patient group that is continuously... more

Risk of hepatic decompensation or HCC is similar in patients with ALD- and MASLD-cirrhosis: A population-based cohort study

13 February 2025
Author(s): Joost Boeckmans, Linnea Widman, Ying Shang, Rickard Strandberg, Axel Wester, Jörn M Schattenberg, Hannes Hagström

Patients with a chronic liver disease often develop liver cirrhosis after a certain time if their disease is not appropriately managed, and cirrhosis was the cause of death in 2.4 % of all deaths... more

Comparative analysis of obesity indices in discrimination and reclassification of cardiovascular disease risk: The ATTICA study (2002–2022)

11 February 2025
Author(s): Sofia-Panagiota Giannakopoulou, Fotios Barkas, Christina Chrysohoou, Evangelos Liberopoulos, Petros P. Sfikakis, Christos Pitsavos, Costas Tsioufis, Demosthenes Panagiotakos

In the mid-2010s, after four decades of consistent decline, the mortality rate from heart disease began to show an increasing trend. This shift was largely attributed to the growing obesity epidemic... more

Characterization of ischemic etiology in heart failure with reduced ejection fraction randomized clinical trials: A systematic review and meta-analysis

11 February 2025
Author(s): Marco Canepa, Gianluca Anastasia, Pietro Ameri, Rocco Vergallo, Christopher M. O'Connor, Gianfranco Sinagra, Italo Porto

Heart failure (HF) is a major cause of cardiovascular (CV) morbidity and mortality in developed countries with rising prevalence due to the aging of the population, the poor control of CV risk... more

Advancing women's health with a pioneering implant to treat breast cancer related lymphedema

11 February 2025
Author(s): L. Mazzolai, V. Triacca, M.J. Brochu-Vez, V. Boucard, M. Aberle, V. Chaplet, V. Ferrari, S. Déglise, M. Pisano, S. Staubli

Lymphedema (LE) is a frequent, but often overlooked condition, with secondary LEs accounting for approximately 82.5% of cases [1]. It typically arises from lymphatic vessel damage or obstruction... more

High-flow nasal oxygen therapy in patients with hypercapnic respiratory failure: A systematic review and meta-analysis

8 February 2025
Author(s): Lili Guan, Jianyi Niu, Qiaoyun Huang, Shanshan Zha, Zhenfeng He, Jieying Hu, Shengchuan Feng, Luqian Zhou, Rongchang Chen

Noninvasive ventilation (NIV) has been used to treat acute respiratory failure for more than 30 years, and it is undoubtedly one of the most important advances in respiratory support [1]. With the... more

Lipoprotein(a) and prothrombotic effects: Evidence from a genetic association study

31 January 2025
Author(s): Elena Olmastroni, Julius L. Katzmann, Federica Galimberti, Ulrich Laufs, Alberico L. Catapano

Lipoprotein(a) [Lp(a)] is an apoB-containing lipoprotein bound to a hydrophilic, highly glycosylated protein called apolipoprotein(a) [apo(a)] [1]. Apo(a) is encoded by the LPA gene, and Lp(a)... more

Risk trajectory of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis

29 January 2025
Author(s): Edoardo Pirera, Domenico Di Raimondo, Lucio D'Anna, Antonino Tuttolomondo

Chronic obstructive pulmonary disease (COPD) is primarily a respiratory condition characterized by irreversible airflow limitation and multiple debilitating symptoms, including dyspnea, cough, and... more

Safety and efficacy of early initiation of sodium-glucose co-transporter inhibitors 2 in patients hospitalized for acute heart failure: A meta-analysis of randomized controlled trials

21 January 2025
Author(s): Renzo Laborante, Donato Antonio Paglianiti, Emiliano Bianchini, Mattia Galli, Josip Andelo Borovac, Gianluigi Savarese, Giuseppe Patti, Domenico D'Amario

Acute heart failure (HF) is a clinical syndrome with multiple aetiologies, among which acute coronary syndrome constitutes one of the most frequent precipitating factors, especially in developed... more

What is the impact of thiamine deficiency on cognitive function in patients with alcohol use disorder? – A systematic review

15 January 2025
Author(s): Joana Teixeira, Inês Pereira, Miguel Castanho, Frederico Simões do Couto

Cognitive impairments, frequently observed in Alcohol Use Disorder (AUD) patients, range from severe memory impairment with other cognitive functions relatively preserved seen in Korsakoff's Syndrome... more

Effects of population-based screening for atrial fibrillation on quality of life

12 January 2025
Author(s): Emilie Katrine Kongebro, Christian Kronborg, Lucas Yixi Xing, Ketil Jørgen Haugan, Claus Graff, Søren Højberg, Morten S Olesen, Derk Krieger, Axel Brandes, Lars Køber, Jesper Hastrup Svendsen, Søren Zöga Diederichsen

Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with an increased risk of stroke, heart failure, and mortality [1]. Many cases of AF remain undetected due to no or... more

Adverse effects of late sleep on physical health in a large cohort of community-dwelling adults

31 December 2024
Author(s): Renske Lok, Lara Weed, Joseph Winer, Jamie M. Zeitzer

Human health is influenced by a myriad of factors, including genetics, environment, and behavior. One behavior that has received significant recent attention is the impact of sleep on human health.... more

Review Article

Tularemia for clinicians: An up-to-date review on epidemiology, diagnosis, prevention and treatment

19 March 2025
Author(s): Roberta Maria Antonello, Andrea Giacomelli, Niccolò Riccardi

After its first description in the 1910s in the Tulare county of California associated with a massive die off of ground squirrels and initially misdiagnosed with bubonic plague, by 1935 tularemia had... more

How to promote healthy aging across the life cycle

19 March 2025
Author(s): Camilla Cocchi, Maria Beatrice Zazzara, Elena Levati, Riccardo Calvani, Graziano Onder

The global population of older adults has grown rapidly in recent years. In Europe, this percentage ranks among the highest, with 21.3 % of the population aged over sixty-five [1]. Projections... more

Comprehensive management of pneumonia in older patients

27 February 2025
Author(s): Alain Putot, Nicolas Garin, Jordi Rello, Virginie Prendki, European Study Group of Infections in the Elderly Patients (ESGIE).

Pneumonia is a bacterial, viral, fungal, or parasitic infection of lung parenchyma, resulting in significant local and systemic inflammation. Pneumonia is the leading infectious cause of... more

Bridging the gap: Time to integrate sex and gender differences into research and clinical practice for improved health outcomes

6 February 2025
Author(s): Roberta Gualtierotti

It is widely recognized that sex and gender interact with factors such as genetic background, ethnicity, socioeconomic status, disability, and age, thus influencing health status and disease. The... more

Beyond creatinine: New methods to measure renal function?

31 January 2025
Author(s): M. Salman Sheikh, Kianoush B. Kashani

The kidneys play a central role in maintaining the body's homeostasis, performing a wide range of vital functions. They eliminate unnecessary and potentially toxic metabolic waste products, such as... more

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness